Viral Threats Research
Abstract
This effort designs and laboratory tests new vaccine candidates against hemorrhagic fever viruses (i.e., dengue virus, Hantaviruses, Lassa fever virus and Crimean-Congo hemorrhagic fever virus) and assesses other non-vaccine technologies to protect against hemorrhagic fever viruses. Efforts also include establishing and maintaining of clinical trial sites worldwide.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2020
- Source ID
- f5b50defab1135ae0e2ac90ab296b27a
Related Documents
- Root: Medical Technology